Funder: Patient-Centered Outcomes Research Institute

Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Full application)

Funding Amounts: Up to $12 million direct costs per project (max 5 years); total program budget up to $60 million.

Summary: Supports rigorous, patient-centered comparative clinical effectiveness research (CER) to improve care, symptom management, or diagnosis in rare diseases, requiring stakeholder engagement.

Key Information: This is a forecasted opportunity; all dates are projected and subject to change.